NCT04037436 2025-04-13
MoveStrong
University of Waterloo
Phase NA Completed
Clinical Trials
29 trialsNCT05779566 2025-02-27
REBECCA-OST
Fundación para la Investigación del Hospital Clínico de Valencia
Completed
NCT04472286 2024-08-30
HBHL
University of Nebraska
Completed
NCT03878134 2023-11-01
Translational Development of Photon-counting CT Imaging
National Institutes of Health Clinical Center (CC)
Phase NA Completed
NCT03408119 2022-10-07
Dried Plums Prevent Inflammation And Improve Bone Health in Osteopenic Men
Florida State University
Phase NA Completed
NCT01613144 2022-02-25
EVOLVE
Alphatec Spine, Inc.
Completed
NCT03386812 2021-01-15
Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer
University of Texas Southwestern Medical Center
Completed
NCT00452439 2020-12-28
A Study of Actonel for the Prevention of Bone Loss
M.D. Anderson Cancer Center
Phase 3 Completed
NCT04213482 2019-12-30
Evaluating Radiomorphometric Indices and Fractal Dimension of the Pediatric Oncology Patients on Panoramic Images
Nuh Naci Yazgan University
Completed
NCT01447914 2019-08-28
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT03076138 2019-05-07
Gene-activated Bone Substitute for Maxillofacial Bone Regeneration
Histograft Co., Ltd.
Phase NA Completed
NCT00089661 2018-10-17
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Amgen
Phase 3 Completed
NCT00980174 2018-10-17
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Amgen
Phase 3 Completed
NCT00824993 2018-09-13
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00211211 2017-12-08
FREE Study - Fracture Reduction Evaluation
Medtronic Spinal and Biologics
Phase 4 Completed
NCT00485953 2017-10-13
REBBeCA II
University of Pittsburgh
Phase 4 Completed
NCT00063609 2017-09-13
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Novartis
Phase 4 Completed
NCT00925600 2017-05-30
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Amgen
Phase 3 Completed
NCT01102985 2015-07-01
Women With Cancer: An Exercise Study to Promote Health
Yale University
Phase NA Completed
NCT01277562 2015-06-08
Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer
City of Hope Medical Center
Completed
NCT00050011 2014-03-21
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Novartis
Phase 3 Completed
NCT00129142 2013-11-15
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
Phase 3 Completed
NCT00859703 2013-10-31
RISAROS
Hospices Civils de Lyon
Phase 3 Completed
NCT00181584 2013-07-11
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT00352846 2013-07-02
Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00766532 2012-09-14
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
University of Wisconsin, Madison
Phase 4 Completed
NCT00171340 2012-04-16
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Novartis
Phase 3 Completed
NCT00082277 2011-01-26
SABRE
AstraZeneca
Phase 4 Completed
NCT00199537 2008-07-29
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Completed